Abstract
Background: Caveolin-1 (CAV1) is a master regulator of cell signaling and membrane transport. CAV1 has been implicated in breast cancer oncogenesis and metastasis and may be a potential prognosticator, especially for non-distant recurrences. Several CAV1 SNPs have been linked to other cancers, however, the prognostic impact of CAV1 SNPs in breast cancer remains unclear. Here, we investigated CAV1 haplotypes association with clinical outcomes in breast cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
